Member Info for DeBull

From BDD

HI Everyone

Could you pass this on to anybody you know who might be looking for a new role. The team at Beyond Blood Diagnostics and Manfredi who is CEO are fantastic and so is the product by the way, a really exciting place to work on cutting edge digital health which is able to make a difference to so many people.

Nice afternoon, would be great to hold this area and see the back of this .75 bottleneck.

This 0.75 area seems a tough nut to crack?

Thank you both for explanations.

Nope...... was just a question that popped into me old head when i saw a HEMO rns, obviously this is not the place to ask questions? Obviously the place to be questioned if you ask a question? i just do not get it.

I dont know, that is why i asked a question!!

What are the chances of this, i ask a genuine question, and get a reply and a "strange suggestion" from our CIC, but i also get a reply from our resident bushwacker saying "casting around for artificial means of boosting the share price" Not only do i get comments from the postivia's here, but also the negatives. What are the chances.......give me strength.

Could PYC benefit from what Hemo have recently done with their 400:1 consolidation?

Https://doseme-rx.com/en-gb/why-dosemerx/drug-packages

When Docetaxel goes from a olive colour to a green colour on the graphic, ie development to validation that is when i would expect a update regarding this collab.

King. Excellent summary.

They are indeed L, however with FDA/PO i would say PYC are trying to harmonise with the FDA initiatives . The FDA as i understand it have not supported PYC to my knowledge......yet!

Whats with the 374625 trades? 5 of them?

Did a £5k trade go through today, as it was mentioned yesterday as being placed?

Great to have another contract with Numab. As King says, does look like its for NM32, however, do not discount NM23. https://numab.com/pipeline/

Bizarre that this and the previous contract not even mentioned on Telegram?

Would like MS view on the chart position? We were heading for a "golden cross" but it needed volume apparently? Has the volume arrived? This 0.75 price seems a tough nut to crack? Anything under .7 gets bought into.

Https://www.pharmaceutical-technology.com/data-insights/innovators-antibody-drug-conjugates-pharmaceutical/?cf-view

Astellas are on this list to. So maybe they can not be discounted from the RNS?

https://www.astellas.com/en/system/files/8a092d5527/2q2024_pip_en.pdf enfortumab vedotin

ASG-22ME

(PADCEV) was approved in Europe in August 2024.

Merck also on this diagram, but does not specify if its Merck or Merck KgAa. However, i have no idea why Royal Caribbean Cruises are on the list tbh.

Lets hope todays gains hold for now, PYC has a history littered with a nice % gains, only to be evaporated the next day.

I doubt its Bicycle, as they maybe "long standing", but they are not "global" yet! Thats my opinion. Bicycle are developing BTC's .

BTCs are much smaller than ADCs (molecular weight ca. 4 kDa vs. ca. 150 kDa), with a physicochemical profile characteristic of renally excreted molecules, and have short plasma half-lives measured in minutes not hours.

Question for Laura, yesterday you said it was very difficult to buy £1000, and yet this morning, there appeared to be no problem in buying £1000 or more? How can that be?

Most likely Merck Kgaa?

https://www.merckgroup.com/en/news/adc-stlouis-29-10-2024.html

https://www.merckgroup.com/en/news/mobius-adc-10-09-2024.html

https://www.fiercepharma.com/manufacturing/merck-kgaas-milliporesigma-production-push-rolls-76m-adc-plant-investment

" long-standing, globally recognised pharmaceutical client."

Https://uk.advfn.com/stock-market/london/physiomics-PYC/share-news/Physiomics-PLC-Contract-Award/95040534

Wasnt the 800k trade a sell? Sent the SP down 7%??

Is this the article, but from another source?

https://www.christianluscher.ch/En19DS25DbF26em.html/2024/12/01/140340/